This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Eubulus Biotherapeutics (Hong Kong) Limited, Other. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 834,453 Years Active: 2026
Title: Xiaolei Wang: Innovator in Pharmaceutical Research
Introduction
Xiaolei Wang is a prominent inventor based in Jiaxing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of GPX4 inhibitors. His work focuses on innovative solutions for treating GPX4-mediated diseases.
Latest Patents
Wang holds a patent for "GPX4 inhibitors, pharmaceutical compositions thereof, and their use for treating GPX4-mediated diseases." This patent outlines the use of GPX4 inhibitors, including a compound of Formula (I), and describes pharmaceutical compositions that can be utilized in treating, preventing, or ameliorating symptoms associated with GPX4-mediated disorders.
Career Highlights
Throughout his career, Xiaolei Wang has worked with Eubulus Biotherapeutics, a company based in Hong Kong. His expertise in pharmaceutical compositions has positioned him as a key player in the development of treatments for complex diseases.
Collaborations
Wang has collaborated with notable professionals in his field, including Sheldon Cao. Their joint efforts have contributed to advancements in pharmaceutical research and development.
Conclusion
Xiaolei Wang's innovative work in the realm of GPX4 inhibitors showcases his dedication to improving healthcare solutions. His contributions are paving the way for new treatments that address critical medical needs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile